On 10 Nov 2026, ALIBABA-W (09988.HK) said HKEX confirmed its spin-off of wholly-owned chip unit T-Head for a Main Board listing via a global offering.
On 10 Nov 2026, SIMCERE PHARMA (02096.HK) said its CD122-targeting antibody SIM0725 received NMPA clinical trial approval for autoimmune diseases.
On 10 Nov 2026, NEAUTUS TCM (02206.HK) priced its global offering at HKD 40.20 each for 6,517,300 H shares, with the Hong Kong offer 2,190.99 times covered.
On 10 Nov 2026, Z.AI (02513.HK) set out an H-share buyback plan of up to HKD 4 billion, capped at 1% of issued shares under a general mandate.
On 10 Nov 2026, CTF SERVICES (00659.HK) agreed to sell Manjue and 25% stakes in two Guangdong toll road operators for about RMB 1.9794 billion in total.
On 10 Nov 2026, BANK OF CHINA (03988.HK) said its Hong Kong Branch is issuing RMB 2.5 billion 1.60% 2028 notes and HKD 1 billion 3.95% 2029 notes for listing.
On 10 November 2026, Neautus (02206.HK) traded at HK$49.50 in the grey market as at 6:08 p.m., up HK$9.30 or 23.13% from its HK$40.20 offer price. The public offer was reportedly about 2,192 times oversubscribed, with a board lot of 50 shares and an entrance fee of HK$2,552.99, ahead of its 11 November listing.
On November 10, the HSI rose 0.44% and the HSTECH 1.08%. MANYCORE TECH led Stock Connect gainers at 25.18%, while southbound funds sold HK$2.739 billion.
On 10 November 2026, Adaspace (06935.HK) entered the final day of its offering at HK$24.90-33.20 per share, with a board lot of 100 shares and an entrance fee of HK$3,353.48, raising up to HK$1.00 billion. Margin financing reached HK$145 million, or 1.45 times the public offer, ahead of a 13 November listing.
On 7 November 2026, Seichitech (688627.SH) said it is planning an overseas H-share offering and a HKEX listing to advance its international strategy and overseas footprint and to attract high-end overseas talent. Details are not yet finalised and the plan will not change control, but requires board, shareholder and regulatory approval.
On 10 November 2026, GRANDPHARMA (00512.HK) said GPN01020, its Class 1.1 Chinese medicine for migraine prevention, enrolled a first patient in a Phase II trial.
On 10 November 2026, SIS INT'L (00529.HK) said its main Thai unit will take 80% of SiS Technologies Vietnam by subscribing to new shares for USD 800,000.
On 10 November 2026, DZUG (01635.HK) said its controlling shareholder pledged 25 million A shares to Bank of Shanghai, lifting pledged holdings to 38.27%.
On November 10, the HSI rose 0.44% and the HSTECH 1.08%, as 18 of the 20 AI concept stocks advanced; ILUVATAR COREX led at 15.49% and Z.AI rose 11.11%.
On November 10, Hong Kong stocks rose, the Hang Seng Index up 0.44% on turnover of 178.2 billion HKD, with southbound net selling of 2.739 billion HKD.
On 10 November 2026, CGN POWER (01816.HK) said Cangnan unit 4 poured first concrete for the nuclear island, starting full construction, with capacity 1,215MW.
